Evaluation of Ascorbate-Meglumine Therapeutic for SRS
Phase 1
Not yet recruiting
- Conditions
- Safety
- Interventions
- Drug: Ascorbate-Meglumine
- First Posted Date
- 2024-05-30
- Last Posted Date
- 2024-05-30
- Lead Sponsor
- LadeRx LLC
- Target Recruit Count
- 12
- Registration Number
- NCT06433791
- Locations
- 🇺🇸
Duke Health, Durham, North Carolina, United States
© Copyright 2025. All Rights Reserved by MedPath